BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26775671)

  • 1. Comparison of 5-Aminolevulinic Acid Photodynamic Therapy and Clobetasol Propionate in Treatment of Vulvar Lichen Sclerosus.
    Shi L; Miao F; Zhang LL; Zhang GL; Wang PR; Ji J; Wang XJ; Huang Z; Wang HW; Wang XL
    Acta Derm Venereol; 2016 Jun; 96(5):684-8. PubMed ID: 26775671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of 5-aminolevulinic acid photodynamic therapy for the treatment of vulvar lichen sclerosus.
    Li Z; Wang Y; Wang J; Li S; Xiao Z; Feng Y; Gu J; Li J; Peng X; Li C; Zeng K
    Photodiagnosis Photodyn Ther; 2020 Mar; 29():101596. PubMed ID: 31704505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of 5-aminolevulinic acid photodynamic therapy for pediatric vulvar lichen sclerosus.
    Zhang S; Wang Y; Wang J; Liu J
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103986. PubMed ID: 38272155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-frequency ultrasound assessment of vulvar lichen sclerosus treated with photodynamic therapy.
    Wang Y; Hao J; Liu J
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103277. PubMed ID: 36621633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with green light for the treatment of vulvar lichen sclerosus - Preliminary results.
    Osiecka BJ; Jurczyszyn K; Nockowski P; Murawski M; Ziółkowski P
    Photodiagnosis Photodyn Ther; 2017 Mar; 17():185-187. PubMed ID: 27919664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Dermoscopic Assessment of Vulvar Lichen Sclerosus After 5-Aminolevulinic Acid Photodynamic Therapy:A Prospective Study.
    Liu J; Hao J; Wang Y; Liu Y; Xu T
    Photodiagnosis Photodyn Ther; 2021 Mar; 33():102109. PubMed ID: 33246149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
    Funaro D; Lovett A; Leroux N; Powell J
    J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy in the treatment of vulvar lichen sclerosus.
    Maździarz A; Osuch B; Kowalska M; Nalewczyńska A; Śpiewankiewicz B
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():135-139. PubMed ID: 28526592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: Series of ten cases.
    Lan T; Zou Y; Hamblin MR; Yin R
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():234-238. PubMed ID: 29258952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy analysis of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus.
    Qu Z; Lin X; Liu M; Wang J; Wang F; Zhang B; Shen L; Wang Z
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104035. PubMed ID: 38442799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposition of standardized protocol for photodynamic therapy for vulvar lichen sclerosus.
    Declercq A; Güvenç C; De Haes P
    J Dermatolog Treat; 2022 Feb; 33(1):560-568. PubMed ID: 32420789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvar lichen sclerosus progressing to squamous cell carcinoma due to the poor compliance for the follow-up after ALA-PDT.
    Shi L; Liu J; Zhang H; Zhang Y; Wang P; Zhang G; Zhou Z; Wang X
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103171. PubMed ID: 36288766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical testosterone versus clobetasol for vulvar lichen sclerosus.
    Ayhan A; Guven S; Guvendag Guven ES; Sakinci M; Gultekin M; Kucukali T
    Int J Gynaecol Obstet; 2007 Feb; 96(2):117-21. PubMed ID: 17239881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy of vulvar lichen sclerosus et atrophicus in a woman with hypothyreosis--case report.
    Osiecka BJ; Nockowski P; Jurczyszyn K; Ziólkowski P
    Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):186-8. PubMed ID: 22594990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of 5-Aminolevulinic Acid (ALA)-Photodynamic Therapy (PDT) in Refractory Vulvar Lichen Sclerosus: Preliminary Results.
    Zhang F; Li D; Shi L; Gu Y; Xu Y; Wu C
    Med Sci Monit; 2021 Jan; 27():e927406. PubMed ID: 33411697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UV-A1 phototherapy vs clobetasol propionate, 0.05%, in the treatment of vulvar lichen sclerosus: a randomized clinical trial.
    Terras S; Gambichler T; Moritz RK; Stücker M; Kreuter A
    JAMA Dermatol; 2014 Jun; 150(6):621-7. PubMed ID: 24696010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful pregnancy and delivery following selective use of photodynamic therapy in treatment of cervix and vulvar diseases.
    Maździarz A
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():65-68. PubMed ID: 31299392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study.
    Günthert AR; Limacher A; Beltraminelli H; Krause E; Mueller MD; Trelle S; Bobos P; Jüni P
    Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():88-95. PubMed ID: 35290878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 5-aminolevulinic acid (ALA)-photodynamic therapy (PDT) for lichen sclerosus of face: case report and literature review.
    Tommasino N; Lauletta G; Spanò G; Scaramuzzino L; De Fata Salvatores G; Scalvenzi M; Coronella L
    Lasers Med Sci; 2024 Jan; 39(1):53. PubMed ID: 38291288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
    Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
    J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.